There are currently 707 clinical trials in San Diego, California looking for participants to engage in research studies. Trials are conducted at various facilities, including University of California, San Diego, Rady Children's Hospital - San Diego, GSK Investigational Site and Naval Medical Center - San Diego. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Cycled Phototherapy
Recruiting
Cycled phototherapy (PT) is likely to increase survival over that with continuous PT among extremely premature infants (\< 750 g BW or \<27 weeks GA).
Gender:
ALL
Ages:
Between 22 weeks and 27 weeks
Trial Updated:
02/04/2025
Locations: Sharp Mary Birch Hospital for Women & Newborns, San Diego, California
Conditions: Hyper Bilirubinemia, Premature Infant
Burn Validation Study
Recruiting
The purpose of this study is to validate the algorithm for burn healing assessment by the Spectral MD DeepView device which would provide burn healing potential assessment.
Gender:
ALL
Ages:
All
Trial Updated:
02/03/2025
Locations: University of California San Diego, San Diego, California
Conditions: Burns, Wound Heal, Wounds and Injuries
Assessing Neurocognition After Cerebrovascular Intervention
Recruiting
Decreased blood flow to the brain can cause decreased cognitive function. Carotid disease can result in decreased blood flow to the brain. The investigators seek to assess this relationship prospectively through performing a battery of neurocognitive assessments, collection of serum markers of inflammation, and through neuroimaging at two points before intervention (2 months and 1 month before stenting) and at two points after intervention (1 month and 2 months after intervention). The goal is t... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/03/2025
Locations: UCSD Medical Center, San Diego, California
Conditions: Carotid Artery Diseases, Neurocognitive Dysfunction
A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
Recruiting
This study will test how well a new medicine called concizumab works for participants who have haemophilia A or B with or without inhibitors. The purpose is to show that concizumab can prevent bleeds and is safe to use. Participants will have to inject the study medicine every day under the skin with a pen-injector. The study will last for at least 2 years and up to about 4 years. The length of time the participant will be in the study depends on if the study medicine will be available for pur... Read More
Gender:
ALL
Ages:
All
Trial Updated:
02/03/2025
Locations: Rady Childrens Hosp San Diego, San Diego, California
Conditions: Haemophilia A and B With and Without Inhibitors
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
Recruiting
The purpose of this study is to evaluate the safety, tolerability, pharmacodynamics (PD) and pharmacokinetics (PK) of a single dose and multiple doses of ALN-APP administered by intrathecal (IT) injection in adult patients with early-onset Alzheimer's Disease (EOAD). Maximum treatment duration for Part A: single dose. Maximum treatment duration for Part B: 12 months.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/03/2025
Locations: Clinical Trial Site, San Diego, California +1 locations
Conditions: Early-Onset Alzheimer Disease
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
Recruiting
The purpose of this study is to evaluate the safety, tolerability, and efficacy of therapeutic vaccination with chimpanzee adenovirus ChAdOx1- and poxvirus modified vaccinia Ankara (MVA)-vectored conserved mosaic T-cell vaccines in a sequential regimen with the toll-like receptor 7 (TLR7) agonist vesatolimod (VES) and two broadly neutralizing antibodies (bNAbs) compared to placebo, to induce HIV-1 control during analytic treatment interruption (ATI).
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/03/2025
Locations: University of California, San Diego AntiViral Research Center CRS, San Diego, California
Conditions: HIV-1-infection
Observational Study to Characterize Biomarkers and Disease Progression in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Recruiting
The purpose of the study is to prospectively assess longitudinal changes in biomarkers (MECP2, potential biomarkers of target engagement and disease activity) in cerebrospinal fluid (CSF) and blood; characterize longitudinal changes in performance on clinical scales (clinician-reported measures of neurodevelopment and functioning) and caregiver-reported outcome assessments (communication, gastrointestinal, social-emotional-adaptive behavioral measures); evaluate longitudinal changes in caregiver... Read More
Gender:
MALE
Ages:
Between 1 month and 65 years
Trial Updated:
02/03/2025
Locations: UCSD - Rady Children's Hospital, San Diego, California
Conditions: Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome
Study Assessing CLENPIQ As Bowel Preparation for Pediatric Colonoscopy
Recruiting
Bowel preparation for pediatric colonoscopy.
Gender:
ALL
Ages:
Between 2 years and 8 years
Trial Updated:
02/03/2025
Locations: Ferring Investigational Site, San Diego, California
Conditions: Bowel Preparation
PS230005 Control-IQ 1.5 Post-Approval Study
Recruiting
This 522 post-market surveillance study is a single-arm, decentralized prospective observational cohort study designed to collect safety data on Control-IQ technology v1.5 in children with type 1 diabetes ages 2 to \<6 years old. Participants will use Control-IQ technology v1.5 for 12 months in the real-world setting.
Gender:
ALL
Ages:
Between 2 years and 5 years
Trial Updated:
01/31/2025
Locations: Tandem Diabetes Care, San Diego, California
Conditions: Type 1 Diabetes
Project Dulce for Filipino-Americans With Type 2 Diabetes
Recruiting
This study aims to culturally adapt an existing American Diabetes Association (ADA)-recognized diabetes self-management and support or DSMES (Diabetes Self Management Education Support) program (Project Dulce) and integrate an evidence-based text messaging program (Dulce Digital) for implementation in Filipino Americans (FAs) with type 2 diabetes mellitus (T2DM). Cultural adaptations aims to facilitate and enhance patient centered approaches and increase participant engagement by addressing barr... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/31/2025
Locations: Scripps Whittier Diabetes Institute, San Diego, California
Conditions: Diabetes Type 2
Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)
Recruiting
This trial will be performed as a three-part dose escalating clinical trial where Parts 1 is open label and Parts 2 and 3 are randomized, double-blinded, and placebo-controlled. The trial is intended to determine the safety and tolerability and assess the preliminary efficacy of briquilimab in adult participants with chronic spontaneous urticaria (CSU), who remain symptomatic despite treatment with H1 antihistamines and omalizumab. Additionally, pharmacokinetic (PK) properties of briquilimab, a... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/31/2025
Locations: Site 105, San Diego, California
Conditions: Chronic Spontaneous Urticaria
Trial for Reliability of Urodynamics SysTem
Recruiting
The goal of this prospective trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question\[s\] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitoring of vesical pressure compared to the vesical pressures collected with conventional urodynamics? Participants will undergo a conventional urodynamics exam, a simultaneous urodynamics exam with GUS, a... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
01/31/2025
Locations: University of California San Diego, San Diego, California
Conditions: Urologic Diseases, Urodynamics